首页> 外国专利> GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS

GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS

机译:公认的二取代NSAID衍生物,获ABETA 42降糖剂

摘要

The present invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, wherein A is the base molecule of a propionic acid or acetic acid NSAID, or a derivative thereof, X is -COSUB2/SUBH, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl and RSUP1 /SUPand RSUP2 /SUPare each independently selected from the group consisting of: CSUB1-6/SUBalkyl and CSUB3-6/SUBcycloalkyl, as well as pharmaceutical composition comprising said compounds and methods of using said compounds. The compounds of the present invention lower the level of AbetaSUB42 /SUBand are therefore useful for preventing, delaying or reversing the progression of Alzheimer's Disease.
机译:本发明包括式I(I)的化合物或其药学上可接受的盐,其中A是丙酸或乙酸NSAID的基础分子或其衍生物,X是-CO 2 H ,1H-四唑-5-基或2H-四唑-5-基和R 1 和R 2 各自独立地选自:C 1-6烷基和C SUB 3 -6环烷基以及包含所述化合物的药物组合物和使用所述化合物的方法。本发明的化合物降低了Abeta 42 的水平,因此可用于预防,延迟或逆转阿尔茨海默氏病的发展。

著录项

  • 公开/公告号EP1587798A4

    专利类型

  • 公开/公告日2007-06-27

    原文格式PDF

  • 申请/专利权人 MERCK & CO. INC.;

    申请/专利号EP20040701220

  • 申请日2004-01-09

  • 分类号C07D207/20;C07D257/04;A61K31/405;A61P25/28;

  • 国家 EP

  • 入库时间 2022-08-21 20:48:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号